Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rugose rose flower, derived from the dried buds of *Rosa rugosa* Thunb., is a prominent botanical drug in Traditional Chinese Medicine (TCM). It is primarily utilized for its ability to regulate Qi, alleviate liver depression, and harmonize blood flow. The chemical profile of the flower is rich in phenolic acids, flavonoids (such as quercetin and kaempferol), and tannins, which contribute to its pharmacological activities, including antioxidant, anti-inflammatory, and potential hepatoprotective effects. Clinically, it is indicated for the treatment of epigastric pain, breast distension, irregular menstruation, and emotional distress associated with Qi stagnation. It is widely available as a raw herb for decoction, a component of patent Chinese medicines, and as a functional tea.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rugose rose flower.